Renaud Vaillant

Renaud Vaillant is Co-Founder & President of Alaya.bio, where he leads corporate strategy, financing, business development, and the advancement of the company’s in vivo CAR-T and gene delivery platform. With more than 20 years of experience in biotechnology, he has guided therapeutic programs from concept through clinical development across oncology, infectious diseases, and genetic diseases. A seasoned entrepreneur, board member, and startup advisor, Renaud has extensive expertise in fundraising, strategic partnerships, company building, and corporate growth, with a track record of translating innovative science into commercially viable businesses and transformative patient solutions.